Comments on: Bye Bye Mr. Buffett http://www.contrarianvalueinvesting.com/2008/08/23/bye-bye-mr-buffett/ Contrarian Value Investing At Its Finest Wed, 03 Feb 2010 03:24:06 -0600 http://wordpress.org/?v=2.8.6 hourly 1 By: Recommended Reading - August 29, 2008 — Old School Value http://www.contrarianvalueinvesting.com/2008/08/23/bye-bye-mr-buffett/comment-page-1/#comment-1161 Recommended Reading - August 29, 2008 — Old School Value Sat, 30 Aug 2008 04:22:31 +0000 http://www.contrarianvalueinvesting.com/?p=113#comment-1161 [...] Bye Bye Mr Buffett by Contrarian Value Investor [...] [...] Bye Bye Mr Buffett by Contrarian Value Investor [...]

]]> By: Alisa http://www.contrarianvalueinvesting.com/2008/08/23/bye-bye-mr-buffett/comment-page-1/#comment-1125 Alisa Wed, 27 Aug 2008 15:03:51 +0000 http://www.contrarianvalueinvesting.com/?p=113#comment-1125 This sounds like a good plan Alex. I am curious about the reference by Chris G to Lexapro. If this is true, will this alter your strategy? Be well. This sounds like a good plan Alex. I am curious about the reference by Chris G to Lexapro. If this is true, will this alter your strategy?

Be well.

]]> By: chris g http://www.contrarianvalueinvesting.com/2008/08/23/bye-bye-mr-buffett/comment-page-1/#comment-968 chris g Sun, 24 Aug 2008 14:34:53 +0000 http://www.contrarianvalueinvesting.com/?p=113#comment-968 You're buying a stock, FRX, that will lose it's number one drug, Lexapro, which accounts for 80% of the sales in 2012. You're hoping that one of the drugs in the pieline will be as successful. That's all there is to this. Of course return on assets and P/E will look good becuase they aren't looking forward. To like this stock at this price you have to assume management can hit another homerun. While that may be possible, it's not with the spirit of the magic formula stock screen. THis is not a stable, ongoing business per se. You’re buying a stock, FRX, that will lose it’s number one drug, Lexapro, which accounts for 80% of the sales in 2012. You’re hoping that one of the drugs in the pieline will be as successful. That’s all there is to this. Of course return on assets and P/E will look good becuase they aren’t looking forward. To like this stock at this price you have to assume management can hit another homerun. While that may be possible, it’s not with the spirit of the magic formula stock screen. THis is not a stable, ongoing business per se.

]]>